✦ LIBER ✦

Role of probiotic therapy in IBD

✍ Scribed by Kim Isaacs; Hans Herfarth

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 105 KB
Volume: 14
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20465

No coin nor oath required. For personal study only.

✦ Synopsis

There is mounting evidence that probiotic therapy may alter disease expression in both animal models of IBD and in patients with IBD. The effects appear to be modest at best and may reflect the choice of probiotic organism, the variability in concentrations of organisms administered, and the variability of the diseases being treated. This review examines the data of all fully published articles currently available for the role of probiotics in the treatment of IBD.

📜 SIMILAR VOLUMES

Maintenance therapy in IBD

✍ Dr. William J. Tremaine 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 1006 KB

Role of probiotic bacteria in sepsis

✍ Tetsuji Fujita 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

I read an excellent and interesting study by Dr. Ewaschuk and colleagues 1 showing the beneficial effects of probiotic compounds on colonic barrier function and the protection of liver in a mouse model of sepsis. The author revealed that a pretreatment with oral probiotics for 7 days could prevent t

Mucosal immune deficiency in IBD: Role o

Mucosal immune deficiency in IBD: Role of IL-4

✍ Stephen P. James 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Lymphocyte homing and its role in the pa

Lymphocyte homing and its role in the pathogenesis of IBD

✍ Bertus Eksteen; Evaggelia Liaskou; David H. Adams 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

Inflammatory bowel disease (IBD) is an idiopathic disorder of chronic inflammation of the gastrointestinal tract. Experimental models of IBD and results from human genomewide linkage studies suggest that the primary defect that leads to IBD is an inappropriate mucosal immune response to normal intes

Phenotype classification in IBD: Is ther

Phenotype classification in IBD: Is there an impact on therapy?

✍ Aaron Walfish; David Sachar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

This review summarizes the current phenotypic classifications of inflammatory bowel disease (IBD) and outlines their implications for diagnosis, therapy, prognosis, clinical trial design, and genotype-phenotype correlations.

On the role of ischemia in the pathogene

On the role of ischemia in the pathogenesis of IBD: A review

✍ Christopher B. Ibrahim; Olga C. Aroniadis; Lawrence J. Brandt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

Inflammatory bowel disease (IBD) is a chronic intestinal disorder comprising 2 distinct but often overlapping diseases: Crohn's disease and ulcerative colitis. Although much research to identify the etiology of IBD has focused on genetic constitution, infectious causes, and immune dysregulation, its